Literature DB >> 30327546

A new guide to immunopharmacology.

Simon D Harding1, Elena Faccenda1, Chris Southan1, Pasquale Maffia2, Jamie A Davies3.   

Abstract

Mesh：

Year:  2018        PMID： 30327546     DOI： 10.1038/s41577-018-0079-2

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  5 in total

1.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY.

Authors:  Jane F Armstrong; Elena Faccenda; Simon D Harding; Adam J Pawson; Christopher Southan; Joanna L Sharman; Brice Campo; David R Cavanagh; Stephen P H Alexander; Anthony P Davenport; Michael Spedding; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

2.  Guide to Immunopharmacology: a database to boost immunology education, research and therapy.

Authors:  Simon Milling; Michael Spedding; Pasquale Maffia
Journal:  Immunology       Date:  2020-05       Impact factor: 7.397

3.  The IUPHAR/BPS guide to PHARMACOLOGY in 2022: curating pharmacology for COVID-19, malaria and antibacterials.

Authors:  Simon D Harding; Jane F Armstrong; Elena Faccenda; Christopher Southan; Stephen P H Alexander; Anthony P Davenport; Adam J Pawson; Michael Spedding; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

Review 4.  The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Authors:  Simon D Harding; Elena Faccenda; Christopher Southan; Adam J Pawson; Pasquale Maffia; Stephen P H Alexander; Anthony P Davenport; Doriano Fabbro; Francesca Levi-Schaffer; Michael Spedding; Jamie A Davies
Journal:  Immunology       Date:  2020-03-02       Impact factor: 7.215

Review 5.  Why do some asthma patients respond poorly to glucocorticoid therapy?

Authors:  Ishbel Henderson; Elisabetta Caiazzo; Charles McSharry; Tomasz J Guzik; Pasquale Maffia
Journal:  Pharmacol Res       Date:  2020-09-08       Impact factor: 7.658
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.